Roby Paul Bhattacharyya, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Candidiasis | 2 | 2024 | 371 | 0.840 |
Why?
|
RNA, Bacterial | 3 | 2019 | 392 | 0.830 |
Why?
|
Bacteria | 7 | 2023 | 2209 | 0.810 |
Why?
|
beta-Lactams | 2 | 2021 | 158 | 0.750 |
Why?
|
Candida | 1 | 2022 | 172 | 0.750 |
Why?
|
Drug Resistance, Bacterial | 4 | 2021 | 1069 | 0.670 |
Why?
|
Nucleic Acid Hybridization | 2 | 2019 | 1306 | 0.600 |
Why?
|
Anti-Bacterial Agents | 8 | 2024 | 7478 | 0.590 |
Why?
|
Campylobacter jejuni | 1 | 2017 | 24 | 0.580 |
Why?
|
Campylobacter Infections | 1 | 2017 | 32 | 0.580 |
Why?
|
Bacteremia | 3 | 2024 | 989 | 0.560 |
Why?
|
Microbial Sensitivity Tests | 3 | 2021 | 1971 | 0.560 |
Why?
|
Liver Failure, Acute | 1 | 2017 | 183 | 0.500 |
Why?
|
Hepatitis, Autoimmune | 1 | 2017 | 170 | 0.480 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1043 | 0.470 |
Why?
|
Viruses | 1 | 2018 | 371 | 0.460 |
Why?
|
Carbapenems | 4 | 2022 | 125 | 0.420 |
Why?
|
Tuberculosis, Splenic | 1 | 2011 | 2 | 0.370 |
Why?
|
Fever of Unknown Origin | 1 | 2011 | 94 | 0.350 |
Why?
|
Communicable Diseases | 1 | 2018 | 874 | 0.340 |
Why?
|
Saccharomyces cerevisiae Proteins | 4 | 2006 | 1833 | 0.280 |
Why?
|
Saccharomyces cerevisiae | 4 | 2022 | 2674 | 0.270 |
Why?
|
Protein Kinases | 3 | 2006 | 1611 | 0.260 |
Why?
|
Pheromones | 1 | 2006 | 93 | 0.250 |
Why?
|
MAP Kinase Signaling System | 3 | 2006 | 1490 | 0.230 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2006 | 1240 | 0.220 |
Why?
|
Sepsis | 3 | 2024 | 2606 | 0.220 |
Why?
|
Enterobacter | 1 | 2022 | 44 | 0.210 |
Why?
|
Dyspnea | 1 | 2011 | 1352 | 0.210 |
Why?
|
Klebsiella pneumoniae | 2 | 2024 | 253 | 0.200 |
Why?
|
DNA, Bacterial | 2 | 2018 | 1477 | 0.200 |
Why?
|
Klebsiella Infections | 1 | 2024 | 146 | 0.200 |
Why?
|
Gene Transfer, Horizontal | 1 | 2022 | 148 | 0.180 |
Why?
|
Protein Conformation | 2 | 2006 | 3946 | 0.180 |
Why?
|
Interferon Type I | 1 | 2024 | 567 | 0.170 |
Why?
|
Fungal Proteins | 2 | 2006 | 899 | 0.160 |
Why?
|
Weight Loss | 1 | 2011 | 2710 | 0.160 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 231 | 0.150 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 323 | 0.150 |
Why?
|
Latent Tuberculosis | 1 | 2021 | 223 | 0.150 |
Why?
|
Virulence | 1 | 2022 | 1289 | 0.150 |
Why?
|
Mycobacterium tuberculosis | 3 | 2019 | 1917 | 0.150 |
Why?
|
Gene Expression Profiling | 4 | 2023 | 9524 | 0.150 |
Why?
|
Evolution, Molecular | 3 | 2021 | 1889 | 0.140 |
Why?
|
Host-Parasite Interactions | 1 | 2019 | 302 | 0.140 |
Why?
|
Alanine | 1 | 2020 | 612 | 0.140 |
Why?
|
Mycobacterium | 1 | 2019 | 253 | 0.140 |
Why?
|
Jaundice | 1 | 2017 | 94 | 0.140 |
Why?
|
Neisseria gonorrhoeae | 1 | 2019 | 248 | 0.130 |
Why?
|
Ribonucleases | 1 | 2017 | 265 | 0.130 |
Why?
|
South Africa | 1 | 2022 | 1867 | 0.130 |
Why?
|
Liver Function Tests | 1 | 2017 | 525 | 0.130 |
Why?
|
Tularemia | 1 | 2016 | 40 | 0.130 |
Why?
|
Gene Library | 2 | 2017 | 1067 | 0.130 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.120 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2035 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2899 | 0.120 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 622 | 0.120 |
Why?
|
Dengue Virus | 1 | 2017 | 202 | 0.120 |
Why?
|
Protein Folding | 1 | 1999 | 869 | 0.120 |
Why?
|
Cross Infection | 1 | 2024 | 1427 | 0.120 |
Why?
|
Phylogeny | 2 | 2019 | 2832 | 0.120 |
Why?
|
Skin Ulcer | 1 | 2016 | 130 | 0.120 |
Why?
|
Pseudomonas aeruginosa | 2 | 2019 | 1276 | 0.120 |
Why?
|
Lab-On-A-Chip Devices | 2 | 2017 | 426 | 0.110 |
Why?
|
RNA, Ribosomal | 1 | 2015 | 227 | 0.110 |
Why?
|
Lymphatic Diseases | 1 | 2016 | 317 | 0.110 |
Why?
|
Inservice Training | 1 | 2016 | 375 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 416 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2017 | 1831 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.100 |
Why?
|
Myocarditis | 1 | 2020 | 802 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2017 | 866 | 0.100 |
Why?
|
Microfluidics | 1 | 2017 | 651 | 0.090 |
Why?
|
Genome, Bacterial | 1 | 2017 | 797 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2199 | 0.090 |
Why?
|
Cuba | 1 | 2011 | 48 | 0.090 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 747 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 938 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1424 | 0.090 |
Why?
|
Models, Molecular | 5 | 2006 | 5379 | 0.080 |
Why?
|
Protein Structure, Secondary | 2 | 2006 | 1210 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3708 | 0.080 |
Why?
|
RNA | 1 | 2019 | 2717 | 0.080 |
Why?
|
Pilot Projects | 1 | 2022 | 8733 | 0.080 |
Why?
|
Humans | 26 | 2024 | 765956 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10070 | 0.080 |
Why?
|
Binding Sites | 3 | 2006 | 6001 | 0.080 |
Why?
|
RNA, Viral | 1 | 2017 | 2864 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1217 | 0.070 |
Why?
|
Phenotype | 3 | 2022 | 16721 | 0.070 |
Why?
|
Signal Transduction | 3 | 2024 | 23600 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1946 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2495 | 0.070 |
Why?
|
Radiography, Abdominal | 1 | 2011 | 544 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2310 | 0.070 |
Why?
|
Myocardium | 1 | 2020 | 4760 | 0.070 |
Why?
|
Tuberculosis | 1 | 2019 | 2012 | 0.070 |
Why?
|
Radiography | 1 | 2017 | 6919 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2780 | 0.060 |
Why?
|
Genomics | 2 | 2024 | 5929 | 0.060 |
Why?
|
Delirium | 1 | 2017 | 1707 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12976 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 13024 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2005 | 634 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 12769 | 0.060 |
Why?
|
Spleen | 1 | 2011 | 2296 | 0.060 |
Why?
|
Allosteric Regulation | 1 | 2006 | 425 | 0.060 |
Why?
|
Crystallography, X-Ray | 2 | 2006 | 1947 | 0.060 |
Why?
|
Protein Structure, Tertiary | 3 | 2006 | 3750 | 0.060 |
Why?
|
Emigrants and Immigrants | 1 | 2011 | 549 | 0.060 |
Why?
|
Base Sequence | 1 | 2015 | 12403 | 0.060 |
Why?
|
Bacterial Proteins | 1 | 2017 | 3837 | 0.050 |
Why?
|
Eukaryotic Cells | 1 | 2004 | 192 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2006 | 924 | 0.050 |
Why?
|
Mutation | 3 | 2022 | 30196 | 0.050 |
Why?
|
Enzyme Activation | 2 | 2006 | 3586 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5753 | 0.050 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2024 | 164 | 0.050 |
Why?
|
Animals | 8 | 2024 | 168759 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 242 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 1999 | 9601 | 0.050 |
Why?
|
Proline | 1 | 2003 | 453 | 0.050 |
Why?
|
Protein Engineering | 1 | 2004 | 550 | 0.050 |
Why?
|
Candida albicans | 1 | 2024 | 377 | 0.040 |
Why?
|
Cathepsin L | 1 | 2020 | 69 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7599 | 0.040 |
Why?
|
Protein Binding | 3 | 2006 | 9296 | 0.040 |
Why?
|
Kidney Glomerulus | 1 | 2021 | 568 | 0.040 |
Why?
|
Cytochrome c Group | 1 | 1999 | 123 | 0.040 |
Why?
|
Models, Biological | 2 | 2006 | 9443 | 0.040 |
Why?
|
Peptides | 2 | 2022 | 4331 | 0.040 |
Why?
|
Lung | 1 | 2017 | 10033 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2022 | 995 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 2927 | 0.040 |
Why?
|
Viscosity | 1 | 1999 | 334 | 0.040 |
Why?
|
Horses | 1 | 1999 | 293 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2020 | 1377 | 0.040 |
Why?
|
Thermodynamics | 1 | 1999 | 580 | 0.030 |
Why?
|
Immunomodulation | 1 | 2021 | 547 | 0.030 |
Why?
|
Dimerization | 1 | 1999 | 880 | 0.030 |
Why?
|
Plasmids | 1 | 2022 | 2274 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 2020 | 746 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 1999 | 697 | 0.030 |
Why?
|
Soil Microbiology | 1 | 2017 | 92 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 839 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1024 | 0.030 |
Why?
|
Clavulanic Acid | 1 | 2014 | 19 | 0.030 |
Why?
|
Phosphorylation | 1 | 2006 | 8278 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2880 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4562 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 845 | 0.030 |
Why?
|
Organizational Policy | 1 | 2016 | 434 | 0.030 |
Why?
|
Dengue | 1 | 2017 | 257 | 0.030 |
Why?
|
Drug Resistance, Microbial | 1 | 2017 | 833 | 0.030 |
Why?
|
Heart Failure | 1 | 2017 | 11840 | 0.030 |
Why?
|
src Homology Domains | 2 | 2004 | 361 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3386 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2412 | 0.020 |
Why?
|
beta-Lactamases | 1 | 2014 | 308 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4850 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2005 | 13400 | 0.020 |
Why?
|
ROC Curve | 1 | 2020 | 3620 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20660 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2024 | 3081 | 0.020 |
Why?
|
Kinetics | 1 | 1999 | 6274 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2536 | 0.020 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 521 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4137 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2005 | 17594 | 0.020 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2020 | 1339 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4528 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2595 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1470 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8701 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2024 | 5343 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3776 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2017 | 1387 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2004 | 3051 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3796 | 0.020 |
Why?
|
Fever | 1 | 2016 | 1603 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10729 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2020 | 3832 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3050 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2004 | 7851 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8871 | 0.020 |
Why?
|
Female | 4 | 2020 | 396101 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3819 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2005 | 53 | 0.020 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2014 | 942 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12795 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10563 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5445 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81818 | 0.010 |
Why?
|
Aged | 1 | 2017 | 171114 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3655 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6309 | 0.010 |
Why?
|
Middle Aged | 3 | 2016 | 223004 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 457 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9338 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2004 | 655 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10383 | 0.010 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2004 | 252 | 0.010 |
Why?
|
Models, Chemical | 1 | 2004 | 608 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20125 | 0.010 |
Why?
|
Male | 3 | 2020 | 363691 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2005 | 2171 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26313 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29921 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24283 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2004 | 1308 | 0.010 |
Why?
|
Cell Cycle | 1 | 2005 | 2920 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54806 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 16047 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41647 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2005 | 2968 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3430 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40065 | 0.010 |
Why?
|
Neoplasms | 1 | 2017 | 22340 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 11888 | 0.000 |
Why?
|